Heidi Neubauer

18PUBLICATIONS
89CO-AUTHORS
Molecular targetsHaematological tumoursInnate immunityPredictive and prognostic markersSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Apr 20, 2026
Preclinical models of hepatosplenic γδ T-cell lymphoma with an activating STAT5B mutation display sensitivity to JAK inhibitor upadacitinib.

|Oct 30, 2025
Multiomics Profiling of T-cell Leukemia and Lymphoma Enables Targeted Therapeutic Discovery.

Aleksandr Ianevski, Kristen Nader, Julia Nguyen

|Apr 15, 2025
Dual STAT3/STAT5 inhibition as a novel treatment strategy in T-prolymphocytic leukemia.

Annika Dechow, Sanna Timonen, Aleksandr Ianevski

|Jun 28, 2024
Optimizing drug combinations for T-PLL: restoring DNA damage and P53-mediated apoptotic responses.

Jana von Jan, Sanna Timonen, Till Braun

|Apr 24, 2024
JAK-STAT signaling maintains homeostasis in T cells and macrophages.

Nikolaus Fortelny, Matthias Farlik, Victoria Fife

|Sep 19, 2023
ABCC1 and glutathione metabolism limit the efficacy of BCL-2 inhibitors in acute myeloid leukemia.

Jessica Ebner, Johannes Schmoellerl, Martin Piontek

Pageof 3

Frequent Collaborators

10 joint publications

Richard Moriggl

5 joint publications

Satu Mustjoki

4 joint publications

Tero Aittokallio

3 joint publications

Helena Sorger